Exact Sciences (EXAS) Receivables - Other (2023 - 2025)

Exact Sciences (EXAS) has 3 years of Receivables - Other data on file, last reported at $31.8 million in Q3 2025.

• Receivables - Other for Q3 2025 came in at $31.8 million, up 23.26% year-over-year; the trailing twelve-month figure through Sep 2025 was $31.8 million (up 23.26% YoY), and the FY2024 annual result was $25.9 million, down 37.89% from the prior year.
• Receivables - Other retreated to $31.8 million in Q3 2025 per EXAS's latest filing, from $32.7 million in the prior quarter.
• Over five years, Receivables - Other peaked at $68.9 million in Q3 2023 and troughed at $25.8 million in Q3 2024.
• A 3-year average of $38.1 million and a median of $32.7 million in 2025 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2024 and 2025: Receivables - Other tumbled 62.55% in 2024, then increased 23.26% in 2025.
• A 3-year view of Receivables - Other shows it stood at $41.7 million in 2023, then slumped by 37.89% to $25.9 million in 2024, then advanced by 22.78% to $31.8 million in 2025.
• Business Quant data shows EXAS's Receivables - Other at $31.8 million in Q3 2025, $32.7 million in Q2 2025, and $29.9 million in Q1 2025.